Qsymia

DRUG2 trials

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), VIVUS LLC

Conditions

Healthy VolunteersObesity

Phase 2

Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate

CompletedNCT01950520

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Healthy Volunteers

Start: 2014-02-07End: 2024-06-11Updated: 2024-10-16

Phase 4

Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects

CompletedNCT02229214

VIVUS LLCObesity

Start: 2014-08-31End: 2014-11-30Updated: 2017-11-07